Interventional Care

We notice that you are visiting us from . This site only services US-based visitors. Would you like to visit the site that is appropriate for your location?
PDI is actively monitoring the monkeypox situation as news continues to become available. Monkeypox is a rare but potentially serious viral illness that has recently been reported in several countries. There are also emerging cases within the United States. Since early May 20221, small clusters of monkeypox have been reported in the United Kingdom and other countries that don’t typically see the disease. This disease is caused by the monkeypox virus and is usually seen within Central and Western Africa.1 Cases outside of Africa are typically caused by travel exposure or close contacts with travelers to Africa.1 The first case in the U.S. was reported in Massachusetts on May 18th after the individual returned from Canada.
As the information around monkeypox continues to evolve, facilities should take the opportunity to ensure that proper infection prevention practices are in place. Many products in our portfolio of Sani-Cloth® disinfectants have an Emerging Viral Pathogen claim and are effective against Monkeypox.1
Transmission from Humans
Human-to-human transmission of the monkeypox virus occurs through close contact with large respiratory droplets from an infected individual, through direct contact with open lesions or body fluids, and through contact with surfaces/clothing that have been contaminated with lesion fluid.2
Prevention in Healthcare
Prevention measures for healthcare facilities include:3
1 Sani-Cloth® Plus Germicidal Disposable Cloth does not have an Emerging Viral Pathogen Claim
2 https://www.cdc.gov/poxvirus/monkeypox/transmission.html
3 https://www.cdc.gov/poxvirus/monkeypox/clinicians/infection-control-hospital.html